ERBB2 and breast cancer: Most of the cases transition between HER2-low and HER2-zero, with the IHC score of the HER2-low decreasing during a relapse biopsy compared to the primary tumor and transitioning it to a HER2-zero status, while the IHC score of the HER2-zero primary BC tends to increase and switch to a HER2-low status.